#USA #Orlando #New England Biolabs #NGS Technology #NEBNext

New England Biolabs Unveils Advanced Technology at the 2026 AGBT Meeting

New England Biolabs (NEB®), a leading name in molecular biology research, is set to reveal groundbreaking updates in Next Generation Sequencing (NGS) library preparation at the upcoming Advances in Genome Biology and Technology (AGBT) Meeting scheduled for February 23-26, 2026, in Orlando, Florida. As a Bronze Meeting Sponsor, NEB will take this opportunity to introduce several enhancements to its NEBNext® product line, which has been instrumental in pushing the boundaries of genomic research.

Exciting Innovations in Sample Preparation Technology

NEB's showcase will include significant advancements in RNA sequencing and innovative solutions for long-read sequencing. Additionally, the company will discuss its recent achievements in enzymatic methyl sequencing (EM-seq™) and surveillance workflows for infectious diseases. These advancements aim to improve accuracy and efficiency in genomic analysis, providing researchers with better tools for understanding complex biological systems.

Among the highlights is the newly launched Monarch® nucleic acid purification solution, specifically the Monarch® Mag Cell-free DNA (cfDNA) Extraction Kit. This kit facilitates the scalable and reproducible isolation of cfDNA from biofluids, which is crucial for applications in liquid biopsies and cancer research.

Expert Presentations on Cutting-edge Research

The AGBT Meeting will feature valuable presentations from distinguished scientists in the field. Dr. Bernard Lam, Associate Director of the Translational Genomics Laboratory at the Ontario Institute for Cancer Research, will deliver a talk titled "Cross-platform evaluation of whole methylome sequencing in research and clinical specimens" during the Bronze Sponsor Workshop on February 25. This presentation will focus on their innovative methods and the implications for future research.

Another exciting product that NEB will launch at the meeting is the NEBNext UltraShear® Long Read, which is designed for enzymatic fragmentation of DNA ranging from 2 to 30 kilobases. Preliminary data suggests significant improvements in sequencing efficiency and direct methylation detection capabilities—an advancement that could revolutionize how researchers approach genomic studies.

Additionally, NEB plans to present findings on its NEBNext Low-bias Small RNA Library Prep Kit. This kit streamlines the library preparation process with a single-day, gel-free workflow based on a proprietary approach that optimizes the ligation of sequencing adapters. This innovation enables precise sequencing across various miRNA and small RNA applications, further enhancing the ease of genomic analyses.

Addressing Global Challenges with Innovative Solutions

NEB's commitment to addressing global health challenges is evident in its focus on agnostic pathogen detection, which is crucial for monitoring diseases in populations. The company will be exhibiting two scientific posters, one of which details successful applications of NEBNext enzymatic methyl sequencing on severely damaged DNA samples, a critical issue in many genetic studies.

Dr. Keerthana Krishnan, Associate Director of NGS Product Development at NEB, expressed enthusiasm for the meeting, stating, "AGBT offers a unique platform for us to present our technological advancements and collaborate directly with fellow scientists who are at the forefront of sequencing innovations." This level of interaction aims to inspire new developments and partnerships in the genomic field.

Visit NEB at AGBT 2026

The NEB team will host various meetings and scientific presentations in the Sarasota Suite at the Signia by Hilton Bonnet Creek Hotel throughout the event. For those interested in exploring the latest advancements in molecular biology, NEB invites attendees to visit their booth and learn more about their cutting-edge technologies and applications.

For further information regarding the NEBNext portfolio for sample preparation, please visit www.NEBNext.com. NEB has been dedicated to the forefront of molecular biology research for over 50 years, focused on creating innovative tools that empower scientists globally.

About New England Biolabs

For more than five decades, New England Biolabs has been pioneering the discovery and manufacturing of essential products designed for research in molecular biology. NEB's commitment to scientific progression mirrors in their ever-evolving product catalog and unwavering support for academic and industry researchers exploring groundbreaking technology applications, particularly in molecular diagnostics and the development of nucleic-acid vaccines. NEB remains a privately held entity with international outreach, bolstered by a robust headquarters in Ipswich, MA, and an expansive distribution network across ten countries. For additional details about NEB, visit www.neb.com.